由Adis國(guó)際有限公司(現(xiàn)在是Wolters Kluwer Health的一部分)出版。石頭:1170 - 229 x?！端幬锱c老齡化》為您提供了關(guān)于老年人群藥物使用、老年疾病和老年對(duì)藥物治療的影響的重要和最新的信息。通過(guò)提供同行評(píng)議的、公正的和可靠的數(shù)據(jù),與衰老的藥物幫助你的評(píng)論文章做出臨床決策和治療選擇基于國(guó)際共識(shí),讓你了解在重要問(wèn)題上,日期與新興治療方法,意識(shí)到特定的藥物治療的地方。該雜志的目的是促進(jìn)老年人的最佳藥物治療，通過(guò)提供一個(gè)定期計(jì)劃的評(píng)論文章，涵蓋臨床藥理學(xué)和病人管理的最重要方面，在這個(gè)獨(dú)特的群體。對(duì)藥物治療有影響的衰老過(guò)程中的生理變化也屬于該雜志的研究范圍。

Published by Adis International Limited (now part of Wolters Kluwer Health). ISSN: 1170-229X.Drugs & Aging provides you with important and current information on drug use in the aging population as well as diseases of the aging and the effects of aging on drug treatment. By providing peer reviewed, impartial and reliable data, the review articles in Drugs & Aging assist you in making clinical decisions and treatment choices based on international consensus, keeping you well informed on important issues, up to date with emerging treatments, and aware of the place of specific drugs in therapy. The Journal aims to promote optimum drug therapy in older adults by providing a regular programme of review articles covering the most important aspects of clinical pharmacology and patient management in this unique group. Physiological changes during aging which have implications for drug therapy also fall within the scope of the Journal.